PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 2022Heliyon154 citationsOpen Access

Cisplatin for cancer therapy and overcoming chemoresistance

RRRanmali RanasingheMMMichael L. MathaiAZAnthony Zulli

Key Points

Key points are not available for this paper at this time.

Abstract

drug delivery systems, biochemical/immune pathways, 2D and 3D cell culture models using small molecule inhibitors and genetic/epigenetic mechanisms, that have contributed to further the understanding of cisplatin's role in modulating the tumour microenvironment. Cisplatin was beneficial in cancer therapy for modulating the putative cellular mechanisms; apoptosis, autophagy, cell cycle arrest and gene therapy of micro RNAs. Specific importance of drug influx, efflux, systemic circulatory toxicity, half-maximal inhibition, and the augmentation of host immunometabolism have been identified. This review offers a discourse on the recent anti-neoplastic treatment strategies to enhance cisplatin efficacy and to overcome chemoresistance, given its superiority among other tolerable chemotherapies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ranasinghe et al. (2022) studied this question.

synapsesocial.com/papers/6a61af23cd947529a9899d71https://doi.org/10.1016/j.heliyon.2022.e10608
Ask AI
Helpful
Bookmark
Share
View Full Paper